K2 HealthVentures
Brigitte Joy currently serves as the VP of Finance at K2 HealthVentures since November 2021, following a similar role at Catalyst Health Ventures from November 2019 to November 2021. Prior to these positions, Brigitte was the Controller at TCV, a prominent growth equity firm, from September 2013 to November 2019, where oversight of the fund accounting team was a key responsibility. Brigitte began a professional career at Ernst & Young LLP as a Manager from January 2007 to September 2013, leading teams and gaining extensive experience in valuation and internal control across various fund types. Brigitte holds a Joint Bachelor of Science in Management and Master of Accountancy in Finance and Accounting from Tulane University, where studies were completed between 2002 and 2006.
K2 HealthVentures
K2 HealthVentures (K2HV) is an alternative investment firm that provides flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. We are healthcare specialists with deep domain expertise, and we understand both the opportunities and challenges that face venture-stage and growth-stage companies. Further, our flat organizational set-up enables nimble decision-making, and our evergreen fund structure allows us to be creative and adapt our facilities to a company’s specific needs over both the short and the long term. Over the last 4 years we have committed more than $1 billion in debt and equity capital to both private and public companies, and our team’s track record spans decades of investing in and supporting innovative life sciences and healthcare companies (with over $4 billion total investments in over 100 portfolio companies).